Data shows that liver cancer is one of the most common and high-risk malignant tumors in China. According to relevant statistics, China accounts for about 50% of the world's new cases and deaths of liver cancer every year. Hepatitis B infection is one of the most important causes of liver cirrhosis and hepatocellular carcinoma. On July 28th, World Hepatitis Day, JD Health held the first "Scientific Liver Protection, Healthy Future" industry forum in Beijing. Industry experts work together to provide advice and strategies for safeguarding the health of the public's liver. "Hepatitis is a silent killer. It has no sense. The liver has no nerves. Only cirrhosis ascites or even liver cancer in the late stage can be found, so we emphasize the importance of hepatitis B screening and daily detection. ”Wang Guiqiang said at the forum that viral hepatitis such as hepatitis B is preventable and curable now, but the public does not pay enough attention to liver disease and self management of the liver is not enough, which will lead to the occurrence of end-stage diseases. So it is important to emphasize the importance of building a "early detection, early diagnosis, early treatment" defense line and chronic disease management. The liver is the 'chemical factory' of the human body, completing over 500 important physiological functions every day, including metabolism, detoxification, secretion, and more. Its health condition directly affects the overall quality of life, and once damaged, it can lead to systemic health problems. ”Yan Jie, chief physician of the Liver Disease Center at Beijing Ditan Hospital, also emphasized that enhancing public awareness of liver protection and promoting early screening and treatment are the key to current liver disease prevention and treatment. If the tumor is detected when it is less than one centimeter, the five-year survival rate can reach 70% -80%. If it reaches advanced liver cancer, the five-year survival rate is only 12%. Currently, 70% -80% of liver cancers screened are in advanced stages, so the popularity of early screening still needs to be improved. Once advanced liver cancer is detected through screening, it is a heavy blow to individuals, families, and society. ”Wang Liqun, vice president of Furui Medical Group and general manager of Furui Pharmaceutical, told China News Health that hepatitis B could not be cured by the current medical means. Liver diseases such as hepatitis B were chronic diseases for life. Follow up management was very important to block the progress of liver disease, which could greatly reduce the incidence of liver cancer. Therefore, it was necessary to popularize early screening. It needed the joint efforts of pharmaceutical enterprises, medical institutions and the whole society to improve public awareness. (New Society)